• Explore /
  • Poster
  • / NEONAX: Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer—A phase II study of the AIO Pancreatic Cancer Group.

NEONAX: Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer—A phase II study of the AIO Pancreatic Cancer Group.

Abstract Poster

Authors

Thomas Ettrich

Thomas Jens Ettrich

Ulm University Hospital, Ulm, Germany

Thomas Jens Ettrich , Andreas W. Berger , Rainer Muche , Manfred P. Lutz , Nicole Prasnikar , Waldemar Uhl , Andrea Tannapfel , Volker Heinemann , Thomas Seufferlein

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT02047513

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr TPS4158)

DOI

10.1200/jco.2014.32.15_suppl.tps4158

Abstract #

TPS4158

Poster Bd #

238A

Abstract Disclosures

Similar Posters

First Author: Waldemar Uhl

First Author: Shawn MacKenzie

First Author: Derek B. Grose

First Author: Vincent Chung